Chlorine in PDB 3nf8: Structural Basis For A New Mechanism of Inhibition of Hiv Integrase Identified By Fragment Screening and Structure Based Design
Protein crystallography data
The structure of Structural Basis For A New Mechanism of Inhibition of Hiv Integrase Identified By Fragment Screening and Structure Based Design, PDB code: 3nf8
was solved by
T.S.Peat,
J.Newman,
J.J.Deadman,
D.Rhodes,
with X-Ray Crystallography technique. A brief refinement statistics is given in the table below:
Resolution Low / High (Å)
|
45.52 /
1.90
|
Space group
|
P 31
|
Cell size a, b, c (Å), α, β, γ (°)
|
71.549,
71.549,
67.099,
90.00,
90.00,
120.00
|
R / Rfree (%)
|
16.9 /
19.8
|
Chlorine Binding Sites:
The binding sites of Chlorine atom in the Structural Basis For A New Mechanism of Inhibition of Hiv Integrase Identified By Fragment Screening and Structure Based Design
(pdb code 3nf8). This binding sites where shown within
5.0 Angstroms radius around Chlorine atom.
In total 6 binding sites of Chlorine where determined in the
Structural Basis For A New Mechanism of Inhibition of Hiv Integrase Identified By Fragment Screening and Structure Based Design, PDB code: 3nf8:
Jump to Chlorine binding site number:
1;
2;
3;
4;
5;
6;
Chlorine binding site 1 out
of 6 in 3nf8
Go back to
Chlorine Binding Sites List in 3nf8
Chlorine binding site 1 out
of 6 in the Structural Basis For A New Mechanism of Inhibition of Hiv Integrase Identified By Fragment Screening and Structure Based Design
Mono view
Stereo pair view
|
A full contact list of Chlorine with other atoms in the Cl binding
site number 1 of Structural Basis For A New Mechanism of Inhibition of Hiv Integrase Identified By Fragment Screening and Structure Based Design within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
A:Cl225
b:55.2
occ:0.70
|
CL25
|
A:CDQ225
|
0.0
|
55.2
|
0.7
|
C1
|
A:CDQ225
|
1.7
|
48.4
|
0.7
|
C6
|
A:CDQ225
|
2.7
|
46.6
|
0.7
|
C2
|
A:CDQ225
|
2.7
|
43.2
|
0.7
|
OD2
|
A:ASP207
|
3.6
|
68.2
|
1.0
|
N
|
A:GLY59
|
3.8
|
30.1
|
1.0
|
C5
|
A:CDQ225
|
3.9
|
46.3
|
0.7
|
O
|
A:HOH220
|
3.9
|
42.4
|
1.0
|
CA
|
A:GLY59
|
4.0
|
27.5
|
1.0
|
C3
|
A:CDQ225
|
4.0
|
43.5
|
0.7
|
CG
|
A:PRO58
|
4.1
|
41.1
|
1.0
|
C
|
A:PRO58
|
4.5
|
33.4
|
1.0
|
C4
|
A:CDQ225
|
4.5
|
43.9
|
0.7
|
CB
|
A:PRO58
|
4.6
|
38.8
|
1.0
|
CG
|
A:ASP207
|
4.7
|
64.0
|
1.0
|
O
|
A:PRO109
|
4.7
|
34.2
|
1.0
|
CB
|
A:PRO109
|
4.8
|
26.7
|
1.0
|
CB
|
A:LYS111
|
4.8
|
27.8
|
1.0
|
O
|
A:PRO58
|
5.0
|
32.3
|
1.0
|
|
Chlorine binding site 2 out
of 6 in 3nf8
Go back to
Chlorine Binding Sites List in 3nf8
Chlorine binding site 2 out
of 6 in the Structural Basis For A New Mechanism of Inhibition of Hiv Integrase Identified By Fragment Screening and Structure Based Design
Mono view
Stereo pair view
|
A full contact list of Chlorine with other atoms in the Cl binding
site number 2 of Structural Basis For A New Mechanism of Inhibition of Hiv Integrase Identified By Fragment Screening and Structure Based Design within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
A:Cl247
b:45.8
occ:0.70
|
CL25
|
A:CDQ247
|
0.0
|
45.8
|
0.7
|
C1
|
A:CDQ247
|
1.7
|
36.5
|
0.7
|
C2
|
A:CDQ247
|
2.6
|
36.6
|
0.7
|
C6
|
A:CDQ247
|
2.8
|
37.4
|
0.7
|
CG1
|
A:VAL77
|
3.9
|
14.4
|
0.5
|
C3
|
A:CDQ247
|
3.9
|
34.7
|
0.7
|
OE1
|
A:GLN62
|
3.9
|
38.8
|
0.5
|
C5
|
A:CDQ247
|
4.0
|
34.1
|
0.7
|
CB
|
A:GLN62
|
4.1
|
20.3
|
0.5
|
CD
|
A:GLN62
|
4.2
|
30.6
|
0.5
|
CG2
|
A:VAL79
|
4.2
|
28.2
|
1.0
|
CB
|
A:GLN62
|
4.2
|
21.9
|
0.5
|
CG1
|
A:VAL150
|
4.4
|
45.4
|
1.0
|
CG
|
A:GLN62
|
4.4
|
19.7
|
0.5
|
C4
|
A:CDQ247
|
4.4
|
35.9
|
0.7
|
CG1
|
A:VAL79
|
4.4
|
31.3
|
1.0
|
CG
|
A:GLN62
|
4.5
|
26.7
|
0.5
|
CG1
|
A:VAL77
|
4.6
|
20.2
|
0.5
|
CB
|
A:VAL79
|
4.7
|
23.8
|
1.0
|
CB
|
A:VAL77
|
4.7
|
19.9
|
0.5
|
CA
|
A:VAL79
|
4.8
|
23.9
|
1.0
|
CG1
|
A:ILE151
|
4.8
|
45.8
|
1.0
|
NE2
|
A:GLN62
|
4.8
|
35.9
|
0.5
|
|
Chlorine binding site 3 out
of 6 in 3nf8
Go back to
Chlorine Binding Sites List in 3nf8
Chlorine binding site 3 out
of 6 in the Structural Basis For A New Mechanism of Inhibition of Hiv Integrase Identified By Fragment Screening and Structure Based Design
Mono view
Stereo pair view
|
A full contact list of Chlorine with other atoms in the Cl binding
site number 3 of Structural Basis For A New Mechanism of Inhibition of Hiv Integrase Identified By Fragment Screening and Structure Based Design within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
A:Cl267
b:37.4
occ:0.70
|
CL25
|
A:CDQ267
|
0.0
|
37.4
|
0.7
|
C1
|
A:CDQ267
|
1.7
|
32.2
|
0.7
|
C2
|
A:CDQ267
|
2.7
|
32.6
|
0.7
|
C6
|
A:CDQ267
|
2.7
|
27.9
|
0.7
|
CB
|
B:TRP132
|
3.2
|
19.2
|
1.0
|
CG
|
B:TRP132
|
3.4
|
22.2
|
1.0
|
CE
|
A:MET178
|
3.5
|
31.6
|
1.0
|
CD2
|
B:TRP132
|
3.7
|
19.3
|
1.0
|
CA
|
B:ALA129
|
3.9
|
18.6
|
1.0
|
C3
|
A:CDQ267
|
4.0
|
33.1
|
0.7
|
C5
|
A:CDQ267
|
4.0
|
31.6
|
0.7
|
CE3
|
B:TRP132
|
4.0
|
21.6
|
1.0
|
CD1
|
B:TRP132
|
4.0
|
24.0
|
1.0
|
CD1
|
B:LEU102
|
4.1
|
23.9
|
1.0
|
CB
|
B:ALA129
|
4.3
|
19.2
|
1.0
|
CD2
|
B:LEU102
|
4.3
|
24.6
|
1.0
|
C4
|
A:CDQ267
|
4.4
|
30.7
|
0.7
|
O
|
B:ALA129
|
4.4
|
19.6
|
1.0
|
O
|
B:ALA128
|
4.5
|
20.7
|
1.0
|
CE2
|
B:TRP132
|
4.6
|
19.4
|
1.0
|
CG
|
A:MET178
|
4.6
|
21.8
|
1.0
|
C
|
B:ALA129
|
4.7
|
19.4
|
1.0
|
N
|
B:ALA129
|
4.7
|
19.0
|
1.0
|
CG
|
B:LEU102
|
4.7
|
22.4
|
1.0
|
CA
|
B:TRP132
|
4.7
|
21.9
|
1.0
|
NE1
|
B:TRP132
|
4.7
|
18.9
|
1.0
|
SD
|
A:MET178
|
4.8
|
31.8
|
1.0
|
CB
|
B:LEU102
|
4.9
|
18.6
|
1.0
|
C
|
B:ALA128
|
5.0
|
21.5
|
1.0
|
|
Chlorine binding site 4 out
of 6 in 3nf8
Go back to
Chlorine Binding Sites List in 3nf8
Chlorine binding site 4 out
of 6 in the Structural Basis For A New Mechanism of Inhibition of Hiv Integrase Identified By Fragment Screening and Structure Based Design
Mono view
Stereo pair view
|
A full contact list of Chlorine with other atoms in the Cl binding
site number 4 of Structural Basis For A New Mechanism of Inhibition of Hiv Integrase Identified By Fragment Screening and Structure Based Design within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
A:Cl277
b:56.2
occ:0.70
|
CL25
|
A:CDQ277
|
0.0
|
56.2
|
0.7
|
C1
|
A:CDQ277
|
1.7
|
49.0
|
0.7
|
C6
|
A:CDQ277
|
2.7
|
45.7
|
0.7
|
C2
|
A:CDQ277
|
2.7
|
42.9
|
0.7
|
OD2
|
B:ASP207
|
3.7
|
68.9
|
1.0
|
C5
|
A:CDQ277
|
3.9
|
46.3
|
0.7
|
N
|
B:GLY59
|
3.9
|
29.8
|
1.0
|
CG
|
B:PRO58
|
4.0
|
39.3
|
1.0
|
O
|
B:HOH231
|
4.0
|
44.6
|
1.0
|
C3
|
A:CDQ277
|
4.0
|
44.0
|
0.7
|
CA
|
B:GLY59
|
4.0
|
27.9
|
1.0
|
C4
|
A:CDQ277
|
4.5
|
44.7
|
0.7
|
C
|
B:PRO58
|
4.5
|
33.9
|
1.0
|
CB
|
B:PRO58
|
4.6
|
38.2
|
1.0
|
O
|
B:PRO109
|
4.7
|
34.5
|
1.0
|
CB
|
B:LYS111
|
4.7
|
23.1
|
0.5
|
CB
|
B:PRO109
|
4.8
|
28.0
|
1.0
|
CD
|
B:PRO58
|
4.9
|
40.9
|
1.0
|
CG
|
B:ASP207
|
4.9
|
66.4
|
1.0
|
CD
|
B:LYS111
|
4.9
|
35.4
|
0.5
|
|
Chlorine binding site 5 out
of 6 in 3nf8
Go back to
Chlorine Binding Sites List in 3nf8
Chlorine binding site 5 out
of 6 in the Structural Basis For A New Mechanism of Inhibition of Hiv Integrase Identified By Fragment Screening and Structure Based Design
Mono view
Stereo pair view
|
A full contact list of Chlorine with other atoms in the Cl binding
site number 5 of Structural Basis For A New Mechanism of Inhibition of Hiv Integrase Identified By Fragment Screening and Structure Based Design within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
B:Cl235
b:34.2
occ:0.70
|
CL25
|
B:CDQ235
|
0.0
|
34.2
|
0.7
|
C1
|
B:CDQ235
|
1.7
|
31.1
|
0.7
|
C2
|
B:CDQ235
|
2.7
|
31.8
|
0.7
|
C6
|
B:CDQ235
|
2.7
|
29.1
|
0.7
|
CB
|
A:TRP132
|
3.2
|
19.2
|
1.0
|
CG
|
A:TRP132
|
3.4
|
22.0
|
1.0
|
CE
|
B:MET178
|
3.6
|
33.2
|
1.0
|
CD2
|
A:TRP132
|
3.7
|
18.7
|
1.0
|
CA
|
A:ALA129
|
3.9
|
19.3
|
1.0
|
C3
|
B:CDQ235
|
3.9
|
31.9
|
0.7
|
CE3
|
A:TRP132
|
4.0
|
20.0
|
1.0
|
C5
|
B:CDQ235
|
4.0
|
32.5
|
0.7
|
CD1
|
A:TRP132
|
4.1
|
23.7
|
1.0
|
CD1
|
A:LEU102
|
4.1
|
23.7
|
1.0
|
CD2
|
A:LEU102
|
4.2
|
24.1
|
1.0
|
CB
|
A:ALA129
|
4.3
|
19.6
|
1.0
|
O
|
B:HOH246
|
4.3
|
58.0
|
1.0
|
O
|
A:ALA129
|
4.4
|
19.2
|
1.0
|
C4
|
B:CDQ235
|
4.4
|
30.8
|
0.7
|
CE2
|
A:TRP132
|
4.5
|
19.7
|
1.0
|
CG
|
B:MET178
|
4.6
|
23.7
|
1.0
|
O
|
A:ALA128
|
4.6
|
21.0
|
1.0
|
CG
|
A:LEU102
|
4.6
|
23.1
|
1.0
|
C
|
A:ALA129
|
4.6
|
19.9
|
1.0
|
N
|
A:ALA129
|
4.7
|
19.8
|
1.0
|
CA
|
A:TRP132
|
4.7
|
20.6
|
1.0
|
NE1
|
A:TRP132
|
4.7
|
21.1
|
1.0
|
SD
|
B:MET178
|
4.8
|
32.2
|
1.0
|
CB
|
A:LEU102
|
4.8
|
17.1
|
1.0
|
CZ3
|
A:TRP132
|
5.0
|
21.9
|
1.0
|
|
Chlorine binding site 6 out
of 6 in 3nf8
Go back to
Chlorine Binding Sites List in 3nf8
Chlorine binding site 6 out
of 6 in the Structural Basis For A New Mechanism of Inhibition of Hiv Integrase Identified By Fragment Screening and Structure Based Design
Mono view
Stereo pair view
|
A full contact list of Chlorine with other atoms in the Cl binding
site number 6 of Structural Basis For A New Mechanism of Inhibition of Hiv Integrase Identified By Fragment Screening and Structure Based Design within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
B:Cl257
b:45.7
occ:0.70
|
CL25
|
B:CDQ257
|
0.0
|
45.7
|
0.7
|
C1
|
B:CDQ257
|
1.7
|
39.5
|
0.7
|
C2
|
B:CDQ257
|
2.6
|
39.4
|
0.7
|
C6
|
B:CDQ257
|
2.7
|
38.5
|
0.7
|
OE1
|
B:GLN62
|
3.7
|
36.7
|
0.4
|
CG1
|
B:VAL77
|
3.8
|
13.0
|
0.4
|
C3
|
B:CDQ257
|
3.9
|
39.4
|
0.7
|
C5
|
B:CDQ257
|
4.0
|
35.4
|
0.7
|
CB
|
B:GLN62
|
4.2
|
20.9
|
0.6
|
CG2
|
B:VAL79
|
4.2
|
27.2
|
1.0
|
CG1
|
B:VAL150
|
4.2
|
45.2
|
1.0
|
CD
|
B:GLN62
|
4.2
|
28.7
|
0.4
|
CG1
|
B:VAL79
|
4.3
|
31.6
|
1.0
|
CB
|
B:GLN62
|
4.4
|
22.6
|
0.4
|
CG
|
B:GLN62
|
4.4
|
22.6
|
0.6
|
C4
|
B:CDQ257
|
4.4
|
38.0
|
0.7
|
CG1
|
B:VAL77
|
4.5
|
20.8
|
0.6
|
CB
|
B:VAL77
|
4.7
|
20.5
|
0.6
|
CB
|
B:VAL79
|
4.7
|
24.5
|
1.0
|
CG
|
B:GLN62
|
4.7
|
25.9
|
0.4
|
CA
|
B:VAL79
|
4.7
|
23.8
|
1.0
|
CG1
|
B:ILE151
|
4.8
|
45.7
|
1.0
|
CG2
|
B:VAL77
|
5.0
|
14.2
|
0.4
|
NE2
|
B:GLN62
|
5.0
|
33.6
|
0.4
|
|
Reference:
D.I.Rhodes,
T.S.Peat,
N.Vandegraaff,
D.Jeevarajah,
G.Le,
E.D.Jones,
J.A.Smith,
J.A.Coates,
L.J.Winfield,
N.Thienthong,
J.Newman,
D.Lucent,
J.H.Ryan,
G.P.Savage,
C.L.Francis,
J.J.Deadman.
Structural Basis For A New Mechanism of Inhibition of Hiv-1 Integrase Identified By Fragment Screening and Structure-Based Design Antivir.Chem.Chemother. V. 21 155 2011.
ISSN: ISSN 0956-3202
PubMed: 21602613
DOI: 10.3851/IMP1716
Page generated: Sun Jul 21 01:00:52 2024
|